For citation: Chan L.L., Chan S.L. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment. Clinical review for general practice. 2024; 5 (7): 24–36. (In Russ.). DOI: 10.47407/kr2024.5.7.00445
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.